Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. [electronic resource]
Producer: 20130503Description: 1128-38 p. digitalISSN:- 1524-4539
- Adolescent
- Adult
- Aged
- Benzamides
- Double-Blind Method
- Exercise Tolerance -- drug effects
- Familial Primary Pulmonary Hypertension
- Female
- Hematoma, Subdural -- chemically induced
- Humans
- Hypertension, Pulmonary -- drug therapy
- Imatinib Mesylate
- Male
- Middle Aged
- Piperazines -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Pyrimidines -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.